Adc Therapeutics SA (NYSE: ADCT) kicked off on Monday, down -8.51% from the previous trading day, before settling in for the closing price of $1.88. Over the past 52 weeks, ADCT has traded in a range of $1.71-$6.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 88.01% over the last five years. While this was happening, its average annual earnings per share was recorded 41.98%. With a float of $77.58 million, this company’s outstanding shares have now reached $96.69 million.
The firm has a total of 162 workers. Let’s measure their productivity. In terms of profitability, gross margin is 89.36%, operating margin of -196.67%, and the pretax margin is -235.56%.
Adc Therapeutics SA (ADCT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adc Therapeutics SA is 19.76%, while institutional ownership is 69.03%. The most recent insider transaction that took place on Dec 11 ’24, was worth 304,500. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $3.04, taking the stock ownership to the 15,666,731 shares. Before that another transaction happened on Dec 11 ’24, when Company’s 10% Owner bought 100,000 for $3.04, making the entire transaction worth $304,500. This insider now owns 13,145,712 shares in total.
Adc Therapeutics SA (ADCT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.98% per share during the next fiscal year.
Adc Therapeutics SA (NYSE: ADCT) Trading Performance Indicators
Take a look at Adc Therapeutics SA’s (ADCT) current performance indicators. Last quarter, stock had a quick ratio of 4.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.40, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.54 in one year’s time.
Technical Analysis of Adc Therapeutics SA (ADCT)
Analysing the last 5-days average volume posted by the [Adc Therapeutics SA, ADCT], we can find that recorded value of 0.69 million was lower than the volume posted last year of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 14.50%. Additionally, its Average True Range was 0.23.
During the past 100 days, Adc Therapeutics SA’s (ADCT) raw stochastic average was set at 2.48%, which indicates a significant decrease from 8.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.61% in the past 14 days, which was lower than the 132.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3322, while its 200-day Moving Average is $3.2093. Now, the first resistance to watch is $1.8283. This is followed by the second major resistance level at $1.9367. The third major resistance level sits at $2.0133. If the price goes on to break the first support level at $1.6433, it is likely to go to the next support level at $1.5667. Now, if the price goes above the second support level, the third support stands at $1.4583.
Adc Therapeutics SA (NYSE: ADCT) Key Stats
The company with the Market Capitalisation of 166.31 million has total of 96,690K Shares Outstanding. Its annual sales at the moment are 69,560 K in contrast with the sum of -240,050 K annual income. Company’s last quarter sales were recorded 18,460 K and last quarter income was -43,970 K.
